These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy. Chan YC; Allen DC; Fialho D; Mills KR; Hughes RA J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):114-6. PubMed ID: 16361609 [TBL] [Abstract][Full Text] [Related]
43. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy. Rajabally YA; Narasimhan M Clin Neurophysiol; 2007 Sep; 118(9):1999-2004. PubMed ID: 17644033 [TBL] [Abstract][Full Text] [Related]
44. [Chronic polyradiculoneuritis and its frontiers]. Vallat JM; Tabaraud F; Magy L; Macian F Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S27-31. PubMed ID: 12690658 [TBL] [Abstract][Full Text] [Related]
45. Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy. Allen JA; Bril V Neurodegener Dis Manag; 2016 Jun; 6(3):237-47. PubMed ID: 27230584 [TBL] [Abstract][Full Text] [Related]
46. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial. Hughes RA Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683 [TBL] [Abstract][Full Text] [Related]
47. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy. Hughes RA Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659 [TBL] [Abstract][Full Text] [Related]
48. Acquired inflammatory demyelinating neuropathies. Ensrud ER; Krivickas LS Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010 [TBL] [Abstract][Full Text] [Related]
49. Are the treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) effective and safe? - A Cochrane Overview summary with commentary. Oaklander AL; Gimigliano F NeuroRehabilitation; 2019; 44(4):609-612. PubMed ID: 31256085 [TBL] [Abstract][Full Text] [Related]
50. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin. Cirillo G; Todisco V; Tedeschi G Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579 [TBL] [Abstract][Full Text] [Related]
51. Update on therapy of chronic immune-mediated neuropathies. Briani C; Cocito D; Campagnolo M; Doneddu PE; Nobile-Orazio E Neurol Sci; 2022 Dec; 43(Suppl 2):605-614. PubMed ID: 33452933 [TBL] [Abstract][Full Text] [Related]
52. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches. Svačina MKR; Lehmann HC Curr Pharm Des; 2022; 28(11):854-862. PubMed ID: 35339172 [TBL] [Abstract][Full Text] [Related]